Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis

References

• Sands BE. Inflammatory bowel disease: past, present, and future. J Gastroenterol 2007; 42: 16–25
   PubMed Web of Science ®Google Scholar
• Bamba T, Matsuda H, Endo M, Fujiyama Y. The pathogenic role of Bacteroides vulgates in patients with ulcerative colitis. J Gastroenterol 1995;30 Suppl:45–7.
   PubMed Web of Science ®Google Scholar
• Nomura T, Ohkusa T, Okayasu I, Yoshida T, Sakamoto M, Hayashi H, et al. Mucosa-associated bacteria in ulcerative colitis before and after antibiotic combination therapy. Aliment Pharmacol Ther 2005; 21: 1017–27
   PubMed Web of Science ®Google Scholar
• Ando A, Sakata S, Koizumi Y, Mitsuyama K, Fujiyama Y, Benno Y. Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis. Inflamm Bowel Dis 2007; 13: 1–8
   Web of Science ®Google Scholar
• Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Fölsch UR, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004; 53: 685–93
   PubMed Web of Science ®Google Scholar
• Berg RD. The indigenous gastrointestinal microflora. Trends Microbiol 1996; 4: 430–5
   PubMed Web of Science ®Google Scholar
• Hayashi H, Sakamoto M, Benno Y. Fecal microbial diversity in a strict vegetarian as determined by molecular analysis and cultivation. Microbiol Immunol 2002; 46: 819–31
   PubMed Web of Science ®Google Scholar
• Suau A, Bonnet R, Sutren M, Gordon JJ, Gibson GR, Collins MD, et al. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 1999; 65: 4799–807
   PubMed Web of Science ®Google Scholar
• Kitts CL. Terminal restriction fragment patterns: a tool for comparing microbial communities and assessing community dynamics. Curr Issues Intest Microbiol 2001; 2: 17–25
   PubMedGoogle Scholar
• Liu WT, Marsh TL, Cheng H, Forney LJ. Characterization of microbial diversity by determining terminal restriction fragment length polymorphisms of genes encoding 16S rRNA. Appl Environ Microbiol 1997; 63: 4516–22
   PubMed Web of Science ®Google Scholar
• Ohkusa T, Nomura T, Terai T, Miwa H, Kobayashi O, Hojo M, et al. Effectiveness of antibiotic combination therapy in patients with active ulcerative colitis: a randomized pilot trial with long-term follow-up. Scand J Gastroenterol 2005; 40: 1334–42
   PubMed Web of Science ®Google Scholar
• Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial. Br Med J 1989; 298: 82–6
   PubMed Web of Science ®Google Scholar
• Marsh TL, Saxman P, Cole J, Tiedje J. Terminal restriction fragment length polymorphism analysis program, a web-based research tool for microbial community analysis. Appl Environ Microbiol 2000; 66: 3616–20
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Sakamoto M, Hayashi H, Benno Y. Novel phylogenetic assignment database for terminal-restriction fragment length polymorphism analysis of human colonic microbiota. J Microbiol Methods 2005; 61: 305–19
   PubMed Web of Science ®Google Scholar
• Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006; 55: 205–11
   PubMed Web of Science ®Google Scholar
• Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006; 124: 837–48
   PubMed Web of Science ®Google Scholar
• Loreau M, Naeem S, Inchausti P, Bengtsson J, Grime JP, Hector A, et al. Biodiversity and ecosystem functioning: current knowledge and future challenges. Science 2001; 294: 804–8
   PubMed Web of Science ®Google Scholar
• McCann KS. The diversity-stability debate. Nature 2000; 405: 228–33
   PubMed Web of Science ®Google Scholar
• Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229–41
   PubMed Web of Science ®Google Scholar
• Ménard S, Candalh C, Banbou JC, Terpend K, Cerf-Bensussan N, Heyman M. Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut 2004; 53: 821–8
   PubMed Web of Science ®Google Scholar
• Baumgart DC, Dignass AU. Intestinal barrier function. Curr Opin Clin Nutr Metab Care 2002; 5: 685–94
   PubMed Web of Science ®Google Scholar
• Lepage P, Seksik P, Sutren M, de la Cochetière MF, Jian R, Marteau P, et al. Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. Inflamm Bowel Dis 2005; 11: 473–80
   PubMed Web of Science ®Google Scholar
• Marteau P, Pochart P, Doré J, Béra-Maillet C, Bernalier A, Corthier G. Comparative study of bacterial groups within the human cecal and fecal microbiota. Appl Environ Microbiol 2001; 67: 4939–42
   PubMed Web of Science ®Google Scholar
• Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans AD, de Vos WM. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 2002; 68: 3401–7
   PubMed Web of Science ®Google Scholar
• Sokol H, Lepage P, Seksik P, Doré J, Marteau P. Molecular comparison of dominant microbiota associated with injured versus healthy mucosa in ulcerative colitis. Gut 2007; 56: 152–4
   PubMed Web of Science ®Google Scholar
• Bibiloni R, Mangold M, Madsen KL, Fedorak RN, Tannock GW. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J Med Microbiol 2006; 55: 1141–9
   PubMed Web of Science ®Google Scholar
• Kleessen B, Kroesen AJ, Buhr HJ, Blaut M. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol 2002; 37: 1034–41
   PubMed Web of Science ®Google Scholar
• Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003; 52: 237–42
   PubMed Web of Science ®Google Scholar